Hello, Guest
Login
Sign Up
 
 

News List: A.P. Pharma, ArcelorMittal, Generex Biotechnology Corporation, Zynga Inc

 
 
Repost This

Dallas, TX -- (SBWIRE) -- 03/19/2013 -- Marketbuzzreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

A.P. Pharma, Inc.(OTC:APPA) shares fell 3.59% and closed at $0.617. The company, on Mar. 8, reported fourth quarter and full year 2012 financial results and highlighted recent corporate progress. The company’s net loss for the fourth quarter of 2012 was $7.7 million, or $0.03 per share, compared to a net loss of $4.3 million, or $0.02 per share, for the fourth quarter of 2011.

How Should Investors Trade APPA After The Recent Price movement? Find out Here

ArcelorMittal (ADR)(NYSE:MT) shares fell 3.51% to $14.29. The company, on Mar. 15, announced the completion of the first instalment of the previously announced investment by a consortium led by POSCO and China Steel Corporation (CSC) to acquire a joint venture interest in ArcelorMittal`s Labrador Trough iron ore mining and infrastructure assets in Quebec, Canada. The consortium acquired an 11.05% interest in the joint venture for total consideration of US$810 million in cash, with ArcelorMittal`s wholly owned subsidiary ArcelorMittal Mines Canada retaining an 88.95% interest in the joint venture.

Is MT a Strong Buying Opportunity After The Recent Slump? Find out Here

Generex Biotechnology Corporation (PINK:GNBT) shares fell 3.65% and closed at $0.0290. The company, on Feb. 7, provided an overview of the current pipeline and potential of its wholly-owned subsidiary Antigen Express, Inc. While the Company is currently in a late Phase IIb trial of a very promising new immunotherapy for early breast cancer (AE37), the Company has made concrete headway in demonstrating a robust pipeline for AE37 indications beyond breast cancer, as well as for the technology behind it.

Is GNBT a Buy After The Latest Price Action? Find Out Here

Zynga Inc (NASDAQ:ZNGA) shares dropped 3.04% to $3.51. Yahoo! Inc. might consider buying ZNGA. Blake Harper, an analyst at Wunderlich Securities Inc., wrote in a research report last week that Yahoo may consider buying Zynga as Chief Executive Officer Marissa Mayer seeks acquisitions to bolster the U.S. Web portal’s mobile and social capabilities. With a market value of about $3 billion, Zynga might be an attractive target if Mayer opts for deals valued at more than $1 billion, Harper said.

Is ZNGA a Buy After The Latest Price Action? Find Out Here

About Marketbuzzreport.com
Marketbuzzreport.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. Marketbuzzreport.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at http://www.marketbuzzreport.com

Disclaimer
The assembled information disseminated by Marketbuzzreport.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Marketbuzzreport.com does expect that investors will buy and sell securities based on information assembled and presented in Marketbuzzreport.com. PLEASE always do your own due diligence, and consult your financial advisor.